Increasing evidence has identified that diabetes mellitus (DM) increases the risk of HFpEF
Park CK, Go EJ, Jo H, Hwang SM, Rahman MM, Park J, Lee JY, Jo YY, Jung Y, Berta T, Kim YH (2024) GLP-1 and its derived peptides mediate Pain Relief through Direct TRPV1 inhibition without affecting Thermoregulation
Why Multi-Receptor Agonists Are a Game-Changer for Adolescent Obesity Despite the success of GLP-1 monotherapy, dual and triple agonists offer significant advantages in obesity treatment by engaging multiple hormonal pathways
IV Insertion : A small IV catheter is inserted into your arm
The GLP-1 agonist dosage was initiated at 0.6 mg/day and increased to 1.2 mg/day without an adverse event
I made the decision in late December to give it a try, hoping to lessen the intense gravitational pull on my aging, arthritic knees